Fundz

Kura Oncology reported raising $150 Million in an initial SEC Form D filing, from an offering of $150 Million

PUBLIC · KURAFeb 05, 2024

Amount Raised

$150 Million

$150 Million sold, per SEC Form D (first sale Jan 26, 2024)

Round Type

Venture

San DiegoBiotechnology Research

Who to call at Kura Oncology, and when

A new round usually means Kura Oncology is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Kura Oncology raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Kura Oncology, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Kura Oncology. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Kura Oncology

Location

San Diego, California, United States

About

Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Our small-molecule drug candidates target signaling pathways and other drivers of cancer where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Kura Oncology raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Kura Oncology's next move

See what Strategic adds

Kura Oncology raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.